NEW YORK CITY—According to the experts, Industry 4.0 no longer is an option.
Leaning at least part way into the evolution now should be seen as a critical business philosophy rather than one that is "nice to have."
And automation and artificial intelligence are not far behind—at once a part of Industry 4.0 and completely autonomous from it—but a necessity for the medical segment nonetheless.
Industry 4.0 can make companies leaner and more efficient with software and improved quality control, but getting the entirety of the working staff to buy in can be a challenge.
Robots today can work in complex environments, but the capital cost can be prohibitive.
The East Coast's largest design and manufacturing event for the medical industry, MD&M East, saw the latest and greatest in micromolding, 3D prototyping and new medical components, as well as the machines that make these processes and parts possible.
The June 12-15 gathering at the Javits Center also brought Justin Brennan, vice president of operations at Philadelphia-based Medical Products Laboratories Inc., and Juan Vega, chief technical officer at New Brunswick, N.J.-based Reliabotics, to discuss these important tangential areas.